Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Arbor Biotechnologiesarbor.bio · Low evidenceArbor Biotechnologies is developing novel gene editing treatments for people living with genetic diseases. The company uses a diverse toolbox of next-generation gene editors to create therapeutic applications across a broad range of conditions.
Parse Score